Seeking Alpha

holydawn

holydawn
Send Message
View as an RSS Feed
View holydawn's Comments BY TICKER:
Latest  |  Highest rated
  • ARMOUR Residential REIT misses by $0.03 [View news story]
    well, as long as they pay their monthly dividend, there will be buyers.
    Jul 31 11:32 PM | 1 Like Like |Link to Comment
  • Inovio cancer drug hits primary endpoint in Phase 2 trial [View news story]
    "Why would data be excluded from analysis? Could be justifiable but to not address it makes me suspicious."

    straw man argument to be precise
    Jul 23 03:19 PM | Likes Like |Link to Comment
  • Inovio cancer drug hits primary endpoint in Phase 2 trial [View news story]
    Yes, it may be justified since there are a variety of reasons why patients would be excluded due to pregnancy, health issues, etc. It's a straw argument at best.
    Jul 23 03:18 PM | 3 Likes Like |Link to Comment
  • Pfizer's Plan B In Immuno-Oncology: Collaboration With Smaller Companies [View article]
    I have to suggest it, could PVCT be looked at by Pfizer since they have members on their board?
    Jun 25 10:15 PM | 1 Like Like |Link to Comment
  • New Residential Investment Corp declares $0.175 dividend [View news story]
    you raise a good point Jack. Obviously, if it goes up to 7, the lower yield will look more reasonable to investors as it may be scaring off others for now.
    Jun 17 11:58 AM | Likes Like |Link to Comment
  • Premarket Gainers / Losers [View news story]
    what a nice list for PVCT to be part of :P
    Jun 12 10:25 AM | 1 Like Like |Link to Comment
  • Provectus settles shareholder derivative lawsuit [View news story]
    more certainty in court cases is always a good thing!
    Jun 12 10:24 AM | Likes Like |Link to Comment
  • ZTE Settlement Could Drive Vringo Shares Substantially Higher [View article]
    people are short since Vringo won't see money for a LONG time.
    Jun 11 01:31 PM | 1 Like Like |Link to Comment
  • Ugly reversal for Inovio [View news story]
    technical basis, really? no, this was mostly emotional. stocks like this aren't technically traded anymore.
    Jun 10 08:56 PM | Likes Like |Link to Comment
  • Too Many Pending Milestones For Me To Sell Inovio [View article]
    this may be most random comment on site.
    Jun 10 12:10 PM | 6 Likes Like |Link to Comment
  • Am I Missing Something Or Is The FDA Dysfunctional? [View instapost]
    Some co-authors reported being employees of Eli Lilly and/or holding company stock. "pretty clear motive"
    Jun 2 11:41 AM | 1 Like Like |Link to Comment
  • What I Did Right, And Did Wrong With PVCT [View instapost]
    Thanks for writing this as I believe others can relate to your experience. However, for many of us, we've held the stock for years and were unable to trade it during what can best be described as a bizarre event when the company name was changed. For example, TD Ameritrade was unable to allow the stock to be traded which panicked many. And, the shorts used this disadvantage to encourage others to sell, mostly out of fear. Always expect attacks on a stock like this regardless of the perceived effectiveness of management. Unfortunately, there are many who wouldn't want a cheaply made drug like this to exist no matter how many people it may help.
    May 29 09:42 PM | 1 Like Like |Link to Comment
  • Well, so much for the uplisting [View news story]
    wow, this is a ridiculous post giving an opinion designed to enable shorts. Seeking Alpha is the poster?
    May 21 12:36 PM | 5 Likes Like |Link to Comment
  • Provectus: Strong Sell, Ties To Paid Stock Promoters, SEC Halt Risk, Price Target $0 [View article]
    whew, best case scenario for serious longs who have actually done DD on pvct. Multiple people short this prior to fda approval, that may be ONLY way these ignorant people go away...
    May 21 12:33 PM | 3 Likes Like |Link to Comment
  • More on Chelsea-Lundbeck deal: Lundbeck gains rights to Northera [View news story]
    any reason to believe short covering will occur above the 6.44 price?
    May 8 09:15 PM | Likes Like |Link to Comment
COMMENTS STATS
127 Comments
73 Likes